Price data is not available
BioHarvest Sciences Inc (BHST) Stock Price, Quote, News & History
BHSTNASDAQ
BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.
You can purchase shares of BioHarvest Sciences (NASDAQ:BHST) through any online brokerage.
Other companies in BioHarvest Sciences’s space includes: Unilever PLC (NYSE:UL), The Estee Lauder Companies Inc (NYSE:EL), e.l.f. Beauty Inc (NYSE:ELF), Interparfums Inc (NASDAQ:IPAR) and Coty Inc (NYSE:COTY).
BioHarvest Sciences has a consensus price target of $9.00.
The stock price for BioHarvest Sciences (NASDAQ: BHST) is $1.69 last updated October 26, 2026 at 7:51 AM EDT.
There are no upcoming dividends for BioHarvest Sciences.
BioHarvest Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for BioHarvest Sciences.
BioHarvest Sciences is in the Consumer Staples sector and Personal Products industry. They are listed on the NASDAQ.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying...
